CANAKINUMAB TREATMENT IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), HIDS/MKD AND TRAPS: EFFICACY IN THE 16 WEEKS RANDOMISED CONTROLLED PHASE AND MAINTENANCE OF DISEASE CONTROL AND SAFETY AT WEEK 40


Creative Commons License

De Benedetti F., Gattorno M., Frenkel J., Calvo I., Moutschen M., Quartier P., ...More

Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.77, (Summary Text) identifier